Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
101.70
-0.30 (-0.29%)
At close: May 24, 2026
-8.54% (1Y)
| Market Cap | 23.49B -14.1% |
| Revenue (ttm) | 14.78B +27.7% |
| Net Income | 1.24B +117.1% |
| EPS | 5.36 +117.1% |
| Shares Out | 231.00M |
| PE Ratio | 18.98 |
| Forward PE | n/a |
| Dividend | 2.10 (2.06%) |
| Ex-Dividend Date | Nov 17, 2025 |
| Volume | 164,145 |
| Open | 102.10 |
| Previous Close | 102.00 |
| Day's Range | 101.50 - 102.50 |
| 52-Week Range | 96.00 - 147.50 |
| Beta | -0.40 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 29, 2026 |